316 related articles for article (PubMed ID: 27419629)
1. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
[TBL] [Abstract][Full Text] [Related]
3. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
Sun H; Rana S; Wang Z; Zhao K; Schnölzer M; Provaznik J; Hackert T; Lv Q; Zöller M
J Oncol; 2019; 2019():3516973. PubMed ID: 31485223
[TBL] [Abstract][Full Text] [Related]
4. Exosomes, metastases, and the miracle of cancer stem cell markers.
Wang Z; Zöller M
Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
[TBL] [Abstract][Full Text] [Related]
5. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract][Full Text] [Related]
6. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
[TBL] [Abstract][Full Text] [Related]
7. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
Wang Z; Zhao K; Hackert T; Zöller M
Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
9. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
Wang H; Rana S; Giese N; Büchler MW; Zöller M
Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
[TBL] [Abstract][Full Text] [Related]
10. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
Yue S; Mu W; Erb U; Zöller M
Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
[TBL] [Abstract][Full Text] [Related]
11. CD44 and EpCAM: cancer-initiating cell markers.
Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
[TBL] [Abstract][Full Text] [Related]
12. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
Mu W; Wang Z; Zöller M
Front Oncol; 2019; 9():1359. PubMed ID: 31921628
[TBL] [Abstract][Full Text] [Related]
13. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
Xie Z; Gao Y; Ho C; Li L; Jin C; Wang X; Zou C; Mao Y; Wang X; Li Q; Fu D; Zhang YF
Gut; 2022 Mar; 71(3):568-579. PubMed ID: 33827783
[TBL] [Abstract][Full Text] [Related]
14. Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells.
Arita T; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Ogino S; Fujita Y; Hiramoto H; Hamada J; Shoda K; Kosuga T; Fujiwara H; Okamoto K; Otsuji E
Oncotarget; 2016 Aug; 7(35):56855-56863. PubMed ID: 27487135
[TBL] [Abstract][Full Text] [Related]
15. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
16. Host matrix modulation by tumor exosomes promotes motility and invasiveness.
Mu W; Rana S; Zöller M
Neoplasia; 2013 Aug; 15(8):875-87. PubMed ID: 23908589
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
[TBL] [Abstract][Full Text] [Related]
18. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
[TBL] [Abstract][Full Text] [Related]
19. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
[TBL] [Abstract][Full Text] [Related]
20. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
